Review paper

Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism

Volume: 174, Issue: 22, Pages: 3986 - 4006
Published: Mar 23, 2017
Abstract
Cardiovascular disease (CVD) is a major cause of morbidity and mortality worldwide. Inflammatory processes arising from metabolic abnormalities are known to precipitate the development of CVD. Several metabolic and inflammatory markers have been proposed for predicting the progression of CVD, including high density lipoprotein cholesterol (HDL-C). For ~50 years, HDL-C has been considered as the atheroprotective 'good' cholesterol because of its...
Paper Details
Title
Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism
Published Date
Mar 23, 2017
Volume
174
Issue
22
Pages
3986 - 4006
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.